Catalyst Wire Dossier Catalyst Wire Dossier

rVIIa-FP

recombinant fusion protein linking coagulation factor VIIa with albumin · CSL Behring
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rVIIa-FP, covering 2017-04-21 to 2017-04-21. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor VIIa With Albumin (rVIIa-FP) in Healthy Male Volunteers [Phase 1]

See pricing